Connect Biopharma Limite... (CNTB)

0.84

-0.07 (-7.68%)

At close: Mar 03, 2025, 3:58 PM

0.87

3.89%

After-hours: Mar 03, 2025, 03:59 PM EST

Connect Biopharma Cash Flow Statement

Table Mode

Year	FY23	FY22	FY21	FY20	FY19
Net Income	-59.38M	-116.12M	-204.94M	-119.37M	-24.46M
Depreciation & Amortization	988K	1.01M	640.98K	221.05K	114.61K
Stock-Based Compensation	3.26M	1.01M	1.41M	590.64K	562.17K
Other Working Capital	12.72M	6.78M	-5.62M	-719.69K	-425.22K
Other Non-Cash Items	-2.28M	-1.35M	6.91K	443.18K	7.69K
Deferred Income Tax	n/a	3.37M	106.37M	89.68M	8.3M
Change in Working Capital	9.48M	7.16M	3.27M	-436.29K	2.38M
Operating Cash Flow	-47.93M	-99.27M	-85.57M	-25.61M	-13.09M
Capital Expenditures	-294K	-4.28M	-7.46M	-2.34M	-155.52K
Acquisitions	2.94M	79.16K	47.73K	53.46K	329.18
Purchase of Investments	-32.6M	-113.7M	-17.98M	-16.33M	-23.65M
Sales Maturities Of Investments	105.19M	34.54M	20.1M	19.12M	23.32M
Other Investing Acitivies	-84K	-79.16K	-47.74K	-53.46K	-329.18
Investing Cash Flow	75.16M	-83.44M	-5.34M	449.15K	-484.7K
Debt Repayment	-290K	-222K	-126K	-82.42K	-63.6K
Common Stock Repurchased	n/a	n/a	-566K	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	n/a	119K	-17.07M	140.83M	7K
Financial Cash Flow	-246K	-91.29K	206.66M	140.74M	-57.45K
Net Cash Flow	27M	-168.93M	109.42M	107.4M	-13.44M
Free Cash Flow	-48.22M	-103.55M	-93.03M	-27.95M	-13.25M